Optimal Management of First-Line Advanced Renal Cell Carcinoma: Focus on Pembrolizumab

Renal cell carcinoma (RCC) is among the 10 most common cancers in the USA. One-third of the patients diagnosed with this cancer present with locally advanced or metastatic disease. In the past, advanced disease conferred poor survival outcomes; however, the treatment paradigm for RCC has been revolu...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Abhay, Singh, Inderpreet, Singh, Namrata, Puzanov, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231754/
https://www.ncbi.nlm.nih.gov/pubmed/32494157
http://dx.doi.org/10.2147/OTT.S215173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231754/
https://www.ncbi.nlm.nih.gov/pubmed/32494157
http://dx.doi.org/10.2147/OTT.S215173

Ejemplares similares